- Papers in database
- 9
- Years active
- 2001 – 2020
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (9)
- 2020Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients10.1371/journal.pone.0238425
- 2020Characterization of Highly Mucus-Adherent Non-GMO Derivatives of Lacticaseibacillus rhamnosus GG10.3389/fbioe.2020.01024
- 2017Lipid-based Nutrient Supplements Do Not Affect Gut Bifidobacterium Microbiota in Malawian Infants: A Randomized Trial10.1097/MPG.0000000000001333
- 2013Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics10.1128/AEM.03467-12
- 2012Bifidobacteriumanimalis subsp. lactis BB-12 Administration in Early Childhood: A Randomized Clinical Trial of Effects on Oral Colonization by Mutans Streptococci and the Probiotic10.1159/000335567
- 2009Probiotics modulate the Bifidobacterium microbiota of elderly nursing home residents10.1007/s11357-008-9081-0
- 2007A probiotic, Lactobacillus fermentum ME-3, has antioxidative capacity in soft cheese spreads with different fats.10.3168/JDS.2006-810
- 2003Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus).10.1016/S1050-4648(03)00023-8
- 2001Lactobacillus crispatus and its nonaggregating mutant in human colonization trials.10.3168/JDS.S0022-0302(01)74559-6